98%
921
2 minutes
20
A standardized procedure for label-free nano-LC-SRM analysis of 32 high-medium abundance proteins from nondepleted human plasma was established and SRM data were acquired on 45 separate days for a control sample that was independently prepared on 39 distinct dates over an 18-month period (542 days). This case study enabled us to assess quantitative variance associated with nano-LC-SRM plasma analysis, mimicking experimental conditions that would be experienced with clinical trial biomarker studies. We assessed sample preparation variability attributed to different technicians and sample storage stability. Instrument performance varied over the 18-month period requiring ion path cleaning, so we assessed the impact of declining performance on specific peptide ion sensitivity and evaluated how various data normalization strategies could compensate for these changes. Our analysis demonstrated that while sample preparation was the main contributor for data variances when MS data were acquired within days, variability in SRM sensitivity was a far greater source of variance when data were acquired over a long period. The overall median multiplexed assay CV was 13% over the 18-month period. This case study is illustrative of large-scale plasma biomarker studies using nano-LC-SRM over extended periods and highlights aspects of bioanalysis that require careful attention to ensure reliable quantitation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/pmic.201500507 | DOI Listing |
Evid Based Dent
September 2025
Dental Core Trainee, Restorative Dentistry, Newcastle Dental Hospital, Cairo, Egypt.
A Commentary On: Mohamed M H, Abouauf E A, Mosallam R S. Clinical performance of class II MOD fiber reinforced resin composite restorations: an 18-month randomized controlled clinical trial. BMC Oral Health 2025;25: 159.
View Article and Find Full Text PDFJ Dev Behav Pediatr
September 2025
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
Objective: We sought to measure whether receipt of an enhanced 18-month well-baby visit with use of a developmental screening tool versus a routine 18-month well-baby visit (which typically involves developmental surveillance without screening) is associated with time to identification of developmental delays.
Method: We conducted a cohort study of children (17-22 months) in Ontario who received an 18-month well-baby visit (March 2020‒March 2022), followed to September 2022 using linked health administrative datasets. Visits were categorized as enhanced (n = 83,554) or routine (n = 15,723).
Cureus
August 2025
Dermatology, Hôpital Privé Francheville, Perigueux, FRA.
Risankizumab (RZB) is a humanized monoclonal antibody that selectively targets interleukin-23 (IL-23). It has proven particularly effective in treating psoriasis, a common chronic inflammatory skin disease. However, its use remains poorly documented in certain populations, including patients with a history of solid organ transplantation or recent/active malignancy.
View Article and Find Full Text PDFAm J Infect Control
September 2025
Department of Nursing (Brooks, Roettger, Schultz, and Krier), Quality (Bates), and Administration (Anil), Mayo Clinic Health System in Southwest Minnesota, Mankato, Minnesota; Department of Automotive and Manufacturing Engineering (Bhandari), Minnesota State University, Mankato, Minnesota. Electroni
Background: Hand hygiene (HH) can help prevent infections in health care settings. Our hospital implemented an electronic HH monitoring system (EHHMS) in fall 2021 to increase HH compliance. Initial improvements decreased below established goals over time.
View Article and Find Full Text PDFBMC Health Serv Res
September 2025
Division of Mental Health Services, Akershus University Hospital, Lørenskog, Norway.
Background: Previous studies have shown that collaboration between primary care and mental health services can enhance accessibility and improve outcomes for patients seen in general practitioners' (GPs') office. There is, however, a lack of empirical evidence regarding the benefits of collaborative care in Norway. This study, part of a larger research project, examined the adaptation and implementation of a successful Canadian collaborative care model developed in Hamilton, Ontario, in three Norwegian GP practices located in different boroughs of Oslo, Norway's largest city.
View Article and Find Full Text PDF